MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) will issue its fiscal 2018 full-year results release on July 30, 2018 after markets close.

MPX Bioceutical Corp. will host a conference call on Tuesday, July 31, 2018 at 10:00 AM Eastern Time.

Participant Dial-In Numbers:
Toll-Free: 1-800-289-0438
Toll / International: 1-323-794-2423
Participants should request the MPX earnings call or provide confirmation code 8723616

Investors are invited to listen via webcast available on the MPX investor section of the Company’s website at https://mpxbioceutical.com/investors/. Please visit the website 15 minutes prior to the call to register, download, and install any necessary audio software. For interested individuals unable to join the conference call, a replay of the call will be available through August 7, 2018, at 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 8723616. The online archive of the webcast will be available on the investor section of the Company’s website for 30 days following the call.

W. Scott Boyes, Chairman, President and Chief Executive Officer of MPX, David McLaren, Chief Financial Officer, and Beth Stavola, Chief Operating Officer, will be answering shareholder questions at the conclusion of the call.